High risk cutaneous squamous cell carcinoma of the head and neck
The majority of patients with head and neck cutaneous squamous cell carcinoma (cSCC) are successfully treated with surgical treatment of the primary site. While only a minority of patients is at risk for regional metastasis, these patients have significantly worse outcomes. Tumor and patient factors...
Guardado en:
Autores principales: | Stephen Y. Kang, Amanda E. Toland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8312bec14a6c42198e11bbc7c4e0a448 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Moaz M. Choudhary, et al.
Publicado: (2016) -
Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
por: Christina Mimikos, et al.
Publicado: (2016) -
Predictors of occult lymph node metastasis in cutaneous head and neck melanoma
por: Jonathan S. Ni, et al.
Publicado: (2019) -
mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
por: Joseph D. Coppock, et al.
Publicado: (2016) -
Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016)